Larotrectinib therapeutic range

Larotrectinib (Larotrectinib) is a targeted therapy used to treat specific types of tumors, mainly targeting TRK (neuronal growth factor receptor) gene fusion-positive tumors. These tumors can occur in different tissues and organs, so the treatment scope of larotrectinib covers multiple cancer types, including but not limited to the following:

1.Tumors in children and adults: Larotrectinib can be used in children and adult patients becauseTRK gene fusion may occur in patients of different ages.

2.Breast cancer: Some breast cancer patients may have TRK gene fusions, so larotrectinib may be a treatment option for these specific subtypes of breast cancer.

3.Lung cancer:TRKgene fusion exists in some patients with non-small cell lung cancer (NSCLC), so larotrectinib can also be used in these patients.

4.Other Cancer Types:TRKGene fusions can also occur in kidney, colorectal, thyroid, pancreatic, and other cancer types. Therefore, the therapeutic scope of larotrectinib extends to these tumors.

It should be emphasized that larotrectinib is only effective for TRK gene fusion-positive tumors. Before larotrectinib is considered, patients usually undergo genetic testing to determine whether TRK gene fusions are present. Treatment plans should be developed by a professional medical team based on the patient's specific circumstances and condition to ensure the best possible outcome.

Patients and doctors should discuss treatment options, including larotrectinib, together to determine whether it is the most appropriate treatment. This drug may provide significant benefit in certain types of tumors but may not work for all cancer patients.

Larotrectinib has been launched in China, but it has not yet been included in medical insurance. Since it has not been launched in China for a long time, it may be difficult to purchase it in China. Please consult the local hospital pharmacy for details. There are original drugs and generic drugs of larotrectinib abroad. The original drugs include German version, American version, European version and Hong Kong version. The price is basically around 20,000 yuan. Generic drugs include Lao and Bangladeshi versions, with prices ranging from two to three thousand. The ingredients of original drugs and generic drugs are basically the same.